Market By Product, Test Type, Technology And Geography | Forecast 2019-2027
Triton Market Research has arrived upon the conclusion that the global market for newborn screening is estimated to snowball with a CAGR of 13.76% in the forecasting period of 2019 to 2027. The market was assessed to be worth $651.84 million in the year 2018 and is predicted to generate a revenue of approximately $2015.86 million by the year 2027.
Newborn screening is the process of screening infants shortly after birth. The conditions vary from treatable diseases to irreversible conditions. Metabolites and enzyme activity from the blood samples are measured by the majority of the newborn screens. Congenital heart defects using pulse oximetry and automated auditory brainstem response are used to determine heart diseases and hearing loss, respectively. If the screening shows positive results, then further testing is done to confirm the disease.
Report scope can be customized per your requirements. Request For Customization
The newborn screening market report from Triton gives a detailed analysis of the market definition, key insights, evolution & transition of newborn screening, Porter’s five force analysis, key impact analysis, market attractiveness index, vendor scorecard, industry components, regulatory framework, industry player positioning and the key market strategies that have been studied for the newborn screening market.
The global newborn screening market is primarily driven by the rising prevalence of diseases among newborns. The newborns suffer from various diseases that include hearing disorders, congenital disorders, neonatal infection, respiratory distress syndrome and others. Newborn screening is performed to seek evidence of certain genetic and endocrine diseases. The screening helps to identify a list of medical conditions, including sickle cell disease (SS, SC, etc.), congenital hypothyroidism (CH), galactosemia (GAL), phenylketonuria, etc.
Key opportunities such as the increasing fertility rates across the globe are creating dynamic growth. Newborn screening helps in the early identification and management of affected newborns, technological advancements in newborn screening and an increase in the number of pregnant women with advanced maternal age are pushing the market growth over the projected period.
The dearth of skilled professionals in the healthcare industry and the maintenance of equipment in hospitals are the key challenges that are curbing the growth of the market globally.
Geographically, the global newborn screening equipment market covers five major regions, which are:
• North America: United States and Canada
• Asia-Pacific: China, Japan, India, South Korea, ASEAN countries, Australia & New Zealand and Rest of Asia-Pacific
• Europe: United Kingdom, Germany, France, Spain, Italy, Russia and Rest of Europe
• Latin America: Brazil, Mexico and Rest of Latin America
• The Middle East and Africa: United Arab Emirates, Turkey, Saudi Arabia, South Africa and Rest of the Middle East & Africa
Global newborn screening market segmentation:
The global newborn screening market segmented on the basis of product, test type and technology:
• By Product has been sub-segmented into:
O Newborn screening instruments
O Newborn screening reagents & assay kits
• By Test type has been sub-segmented into:
O Hearing screen test
O Critical congenital heart disease (CCHD) Test
O Dry blood spot test
• By Technology has been sub-segmented into:
O Tandem Mass Spectrometry
O Pulse Oximetry
O Enzyme-based assays
O DNA-based assays
O Electrophoresis
O Others
The top companies that have been studied in the market are Medtronic Plc, PerkinElmer Inc., Waters Corporation, Thermo Fisher Scientific Inc., NeoGen Labs Pvt. Ltd., Bio-Rad Laboratories Inc., Agilent Technologies Inc., Natus Medical, Incorporated, Trivitron Healthcare, GE Healthcare, Masimo Corporation, ZenTech S.A., Cardinal Health Inc., SCIEX and BioTek Instruments Inc.
The strategic analysis for each of these companies in the newborn screening market has been covered in detail. The company market share helps in diving into the information about the key market players and the hold of each company on the market.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. GLOBAL NEWBORN SCREENING MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. KEY INSIGHTS
2.2.1. SUPPORTIVE GOVERNMENT POLICIES IN US AND
CANADA
2.2.2. DEMAND FOR NEWBORN SCREENING INSTRUMENTS IS
RISING STEADILY
2.2.3. GROWTH IN DRY BLOOD SPOT TEST
2.2.4. TECHNIQUES USED IN NEWBORN SCREENING TESTS
2.3. EVOLUTION & TRANSITION OF NEWBORN
SCREENING
2.4. PORTER’S FIVE FORCE ANALYSIS
2.4.1. THREAT OF NEW ENTRANTS
2.4.2. THREAT OF SUBSTITUTE
2.4.3. BARGAINING POWER OF SUPPLIERS
2.4.4. BARGAINING POWER OF BUYERS
2.4.5. THREAT OF COMPETITIVE RIVALRY
2.5. KEY IMPACT ANALYSIS
2.5.1. RELIABILITY
2.5.2. COST
2.5.3. AVAILABILITY
2.5.4. TECHNOLOGICAL ADVANCEMENT
2.6. MARKET ATTRACTIVENESS INDEX
2.7. VENDOR SCORECARD
2.8. INDUSTRY COMPONENTS
2.8.1. RAW MATERIAL SUPPLIERS
2.8.2. MANUFACTURERS
2.8.3. DISTRIBUTORS
2.8.4. END-USERS
2.9. REGULATORY FRAMEWORK
2.10. INDUSTRY PLAYER POSITIONING
2.11. KEY MARKET STRATEGIES
2.11.1. PRODUCT LAUNCH
2.12. MARKET DRIVERS
2.12.1. INCREASE IN OCCURRENCES OF NEWBORN DISEASES
2.12.2. GROWING NUMBER OF INFANTS WITH BIRTH DEFECT
2.12.3. BACKING OF GOVERNMENT TOWARDS NEWBORN CHILD
HEALTH
2.12.4. RISING AWARENESS FOR PEDIATRIC CONGENITAL
HEART DISEASE
2.13. MARKET RESTRAINTS
2.13.1. ABSENCE OF PROPER HEALTHCARE INFRASTRUCTURE
FOR NEWBORN BABIES IN DEVELOPING COUNTRIES
2.13.2. SOCIO-ECONOMIC HURDLES IN THE IMPLEMENTATION
OF NEWBORN CHILD SCREENING
2.14. MARKET OPPORTUNITIES
2.14.1. INCREASING FERTILITY RATES ACROSS THE GLOBE
IS CREATING DYNAMIC GROWTH
2.14.2. NEWBORN SCREENING HELPS IN EARLY
IDENTIFICATION AND MANAGEMENT OF AFFECTED NEWBORNS
2.14.3. TECHNOLOGICAL ADVANCEMENTS IN NEWBORN
SCREENING
2.14.4. INCREASE IN NUMBER OF PREGNANT WOMEN WITH
ADVANCED MATERNAL AGE
2.15. MARKET CHALLENGES
2.15.1. DEARTH OF SKILLED PROFESSIONAL IN HEALTHCARE
INDUSTRY
2.15.2. MAINTENANCE OF EQUIPMENT IN HOSPITAL
3. NEWBORN SCREENING MARKET OUTLOOK - BY PRODUCT
3.1. NEWBORN SCREENING INSTRUMENTS
3.2. NEWBORN SCREENING REAGENTS & ASSAY KITS
4. NEWBORN SCREENING MARKET OUTLOOK - BY TEST
TYPE
4.1. HEARING SCREEN TEST
4.2. CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST
4.3. DRY BLOOD SPOT TEST
5. NEWBORN SCREENING MARKET OUTLOOK - BY
TECHNOLOGY
5.1. TANDEM MASS SPECTROMETRY
5.2. PULSE OXIMETRY
5.3. ENZYME-BASED ASSAYS
5.4. DNA-BASED ASSAYS
5.5. ELECTROPHORESIS
5.6. OTHERS
6. NEWBORN SCREENING MARKET - REGIONAL OUTLOOK
6.1. NORTH AMERICA
6.1.1. MARKET BY PRODUCT
6.1.2. MARKET BY TEST TYPE
6.1.3. MARKET BY TECHNOLOGY
6.1.4. COUNTRY ANALYSIS
6.1.4.1. UNITED STATES
6.1.4.2. CANADA
6.2. EUROPE
6.2.1. MARKET BY PRODUCT
6.2.2. MARKET BY TEST TYPE
6.2.3. MARKET BY TECHNOLOGY
6.2.4. COUNTRY ANALYSIS
6.2.4.1. UNITED KINGDOM
6.2.4.2. GERMANY
6.2.4.3. FRANCE
6.2.4.4. SPAIN
6.2.4.5. ITALY
6.2.4.6. RUSSIA
6.2.4.7. REST OF EUROPE
6.3. ASIA-PACIFIC
6.3.1. MARKET BY PRODUCT
6.3.2. MARKET BY TEST TYPE
6.3.3. MARKET BY TECHNOLOGY
6.3.4. COUNTRY ANALYSIS
6.3.4.1. CHINA
6.3.4.2. JAPAN
6.3.4.3. INDIA
6.3.4.4. SOUTH KOREA
6.3.4.5. ASEAN COUNTRIES
6.3.4.6. AUSTRALIA & NEW ZEALAND
6.3.4.7. REST OF ASIA-PACIFIC
6.4. LATIN AMERICA
6.4.1. MARKET BY PRODUCT
6.4.2. MARKET BY TEST TYPE
6.4.3. MARKET BY TECHNOLOGY
6.4.4. COUNTRY ANALYSIS
6.4.4.1. BRAZIL
6.4.4.2. MEXICO
6.4.4.3. REST OF LATIN AMERICA
6.5. MIDDLE EAST AND AFRICA
6.5.1. MARKET BY PRODUCT
6.5.2. MARKET BY TEST TYPE
6.5.3. MARKET BY TECHNOLOGY
6.5.4. COUNTRY ANALYSIS
6.5.4.1. UNITED ARAB EMIRATES
6.5.4.2. TURKEY
6.5.4.3. SAUDI ARABIA
6.5.4.4. SOUTH AFRICA
6.5.4.5. REST OF MIDDLE EAST & AFRICA
7. COMPETITIVE LANDSCAPE
7.1. SCIEX
7.2. BIOTEK INSTRUMENTS, INC.
7.3. BIO-RAD LABORATORIES, INC.
7.4. CARDINAL HEALTH, INC.
7.5. GE HEALTHCARE, LIMITED
7.6. AGILENT TECHNOLOGIES, INC.
7.7. MASIMO CORPORATION
7.8. NATUS MEDICAL, INCORPORATED
7.9. MEDTRONIC PLC
7.10. THERMO FISHER SCIENTIFIC, INC.
7.11. NEOGEN LABS PVT. LTD.
7.12. PERKINELMER, INC.
7.13. ZENTECH S.A.
7.14. WATERS CORPORATION
7.15. TRIVITRON HEALTHCARE
8. METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY
TABLE 1: GLOBAL NEWBORN SCREENING MARKET, BY GEOGRAPHY, 2019-2027 (IN $
MILLION)
TABLE 2: MARKET ATTRACTIVENESS INDEX
TABLE 3: VENDOR SCORECARD
TABLE 4: REGULATORY FRAMEWORK
TABLE 5: LIST OF PRODUCT LAUNCHES
TABLE 6: GLOBAL INCIDENCE OF CHROMOSOMAL ABNORMALITIES IN NEWBORNS
TABLE 7: LEADING CAUSE OF INFANT DEATHS IN THE UNITED STATES
TABLE 8: INFANT MORTALITY RATE IN DEVELOPING COUNTRIES (TOTAL DEATHS/
1000 LIVE BIRTHS)
TABLE 9: GLOBAL NEWBORN SCREENING MARKET, BY PRODUCT, 2019-2027 (IN $
MILLION)
TABLE 10: GLOBAL NEWBORN SCREENING MARKET, BY TEST TYPE, 2019-2027 (IN $
MILLION)
TABLE 11: GLOBAL NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019-2027 (IN
$ MILLION)
TABLE 12: GLOBAL NEWBORN SCREENING MARKET, BY GEOGRAPHY, 2019-2027 (IN $
MILLION)
TABLE 13: NORTH AMERICA NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027
(IN $ MILLION)
TABLE 14: NORTH AMERICA NEWBORN SCREENING MARKET, BY PRODUCT, 2019-2027
(IN $ MILLION)
TABLE 15: NORTH AMERICA NEWBORN SCREENING MARKET, BY TEST TYPE,
2019-2027 (IN $ MILLION)
TABLE 16: NORTH AMERICA NEWBORN SCREENING MARKET, BY TECHNOLOGY,
2019-2027 (IN $ MILLION)
TABLE 17: EUROPE NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027 (IN $
MILLION)
TABLE 18: EUROPE NEWBORN SCREENING MARKET, BY PRODUCT, 2019-2027 (IN $
MILLION)
TABLE 19: EUROPE NEWBORN SCREENING MARKET, BY TEST TYPE, 2019-2027 (IN $
MILLION)
TABLE 20: EUROPE NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019-2027 (IN
$ MILLION)
TABLE 21: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027
(IN $ MILLION)
TABLE 22: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY PRODUCT, 2019-2027
(IN $ MILLION)
TABLE 23: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY TEST TYPE, 2019-2027
(IN $ MILLION)
TABLE 24: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY TECHNOLOGY,
2019-2027 (IN $ MILLION)
TABLE 25: LATIN AMERICA NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027
(IN $ MILLION)
TABLE 26: LATIN AMERICA NEWBORN SCREENING MARKET, BY PRODUCT, 2019-2027
(IN $ MILLION)
TABLE 27: LATIN AMERICA NEWBORN SCREENING MARKET, BY TEST TYPE,
2019-2027 (IN $ MILLION)
TABLE 28: LATIN AMERICA NEWBORN SCREENING MARKET, BY TECHNOLOGY,
2019-2027 (IN $ MILLION)
TABLE 29: MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY COUNTRY,
2019-2027 (IN $ MILLION)
TABLE 30: MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY PRODUCT,
2019-2027 (IN $ MILLION)
TABLE 31: MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY TEST TYPE,
2019-2027 (IN $ MILLION)
TABLE 32: MIDDLE EAST AND AFRICA NEWBORN SCREENING MARKET, BY
TECHNOLOGY, 2019-2027 (IN $ MILLION)
FIGURE 1: PORTER’S FIVE FORCE ANALYSIS
FIGURE 2: KEY BUYING IMPACT ANALYSIS
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: INDUSTRY PLAYER POSITIONING IN 2018 (IN %)
FIGURE 5: CAUSES OF DEATH AMONG NEWBORNS WORLDWIDE (0-27 DAYS)
FIGURE 6: FERTILITY RATE (AVERAGE BIRTHS PER WOMAN IN %) IN 2017
FIGURE 7: GLOBAL NEWBORN SCREENING MARKET, BY NEWBORN SCREENING
INSTRUMENTS, 2019-2027 (IN $ MILLION)
FIGURE 8: GLOBAL NEWBORN SCREENING MARKET, BY NEWBORN SCREENING REAGENTS
& ASSAY KITS, 2019-2027 (IN $ MILLION)
FIGURE 9: GLOBAL NEWBORN SCREENING MARKET, BY HEARING SCREEN TEST,
2019-2027 (IN $ MILLION)
FIGURE 10: GLOBAL NEWBORN SCREENING MARKET, BY CRITICAL CONGENITAL HEART
DISEASE (CCHD) TEST, 2019-2027 (IN $ MILLION)
FIGURE 11: GLOBAL NEWBORN SCREENING MARKET, BY DRY BLOOD SPOT TEST,
2019-2027 (IN $ MILLION)
FIGURE 12: GLOBAL NEWBORN SCREENING MARKET, BY TANDEM MASS SPECTROMETRY,
2019-2027 (IN $ MILLION)
FIGURE 13: GLOBAL NEWBORN SCREENING MARKET, BY PULSE OXIMETRY, 2019-2027
(IN $ MILLION)
FIGURE 14: GLOBAL NEWBORN SCREENING MARKET, BY ENZYME-BASED ASSAY, 2019-2027
(IN $ MILLION)
FIGURE 15: GLOBAL NEWBORN SCREENING MARKET, BY DNA-BASED ASSAYS,
2019-2027 (IN $ MILLION)
FIGURE 16: GLOBAL NEWBORN SCREENING MARKET, BY ELECTROPHORESIS,
2019-2027 (IN $ MILLION)
FIGURE 17: GLOBAL NEWBORN SCREENING MARKET, BY OTHERS, 2019-2027 (IN $
MILLION)
FIGURE 18: GLOBAL NEWBORN SCREENING MARKET, REGIONAL OUTLOOK, 2018 &
2027 (IN %)
FIGURE 19: UNITED STATES NEWBORN SCREENING MARKET, 2019-2027 (IN $
MILLION)
FIGURE 20: CANADA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 21: UNITED KINGDOM NEWBORN SCREENING MARKET, 2019-2027 (IN $
MILLION)
FIGURE 22: GERMANY NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 23: FRANCE NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 24: SPAIN NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 25: ITALY NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 26: RUSSIA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 27: REST OF EUROPE NEWBORN SCREENING MARKET, 2019-2027 (IN $
MILLION)
FIGURE 28: CHINA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 29: JAPAN NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 30: INDIA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 31: SOUTH KOREA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 32: ASEAN COUNTRIES NEWBORN SCREENING MARKET, 2019-2027 (IN $
MILLION)
FIGURE 33: AUSTRALIA & NEW ZEALAND NEWBORN SCREENING MARKET,
2019-2027 (IN $ MILLION)
FIGURE 34: REST OF ASIA-PACIFIC NEWBORN SCREENING MARKET, 2019-2027 (IN
$ MILLION)
FIGURE 35: BRAZIL NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 36: MEXICO NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 37: REST OF LATIN AMERICA NEWBORN SCREENING MARKET, 2019-2027 (IN
$ MILLION)
FIGURE 38: UNITED ARAB EMIRATES NEWBORN SCREENING MARKET, 2019-2027 (IN
$ MILLION)
FIGURE 39: TURKEY NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 40: SAUDI ARABIA NEWBORN SCREENING MARKET, 2019-2027 (IN $
MILLION)
FIGURE 41: SOUTH AFRICA NEWBORN SCREENING MARKET, 2019-2027 (IN $
MILLION)
FIGURE 42: REST OF MIDDLE EAST & AFRICA NEWBORN SCREENING MARKET,
2019-2027 (IN $ MILLION)